| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 |
| filingDate |
2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349c2ae6b0869c8b76dac837d3e87f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df938d3ea6d44322506931136f88875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c909198477c08aab098daa19ed448c14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_732fbbdbc3c17fcd35496792ae6aa255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4a6983a322f05ef1efa7352e7bb07c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb052a13f824172a7f6ddcfa28f8e423 |
| publicationDate |
2006-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2275926-C2 |
| titleOfInvention |
Method for correcting cytolytic syndrome in chronic hepatitis cases |
| abstract |
FIELD: medicine. n SUBSTANCE: method involves administering Corbiculin at a dose of 2 g three times a day when prediluted with 50 ml of water. The treatment course is 21 days long or longer until alanine aminotransferase and aspartate aminotransferase indices assume normal values. n EFFECT: enhanced effectiveness in normalizing hyperenzymemia and relieving clinic manifestations of cytolytic syndrome. n 2 tbl |
| priorityDate |
2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |